HEALTHSTORY 512· AUGUST 12, 2026

Autoimmune research pioneer Georg Schett co-founds his first biotech, choosing antibody therapies over CAR-T

Georg Schett, the German scientist who spent five years demonstrating that CAR-T therapy, a treatment that engineers a patient's own immune cells to target and eliminate the source of disease, can reset the immune system in autoimmune…

NDNewsDialy Desk2 MIN READ

SOURCE

statnews.com

← PREVIOUS STORY 511Arko Petroleum agrees to buy U.S. Petroleum Partners for $205 million NEXT STORY 513 →Oil prices rise as attacks on vessels in the Red Sea and Gulf of Oman stoke supply fears

Keep reading

More from the desk.

03HEALTH

Radiopharma giants merge in $1.65 billion deal after FDA rejection

Two leading radiopharmaceutical companies are merging in a transaction valued at at least $1.65 billion. This move follows a surprise FDA rejection for one of the firms. In plain terms, radiopharmaceuticals are medicines that deliver…

health2 MIN

26HEALTH

Sanfilippo syndrome gets its first gene therapy approval after more than a decade of research

A rare childhood disease called Sanfilippo syndrome now has an approved gene therapy, the first one in the disease's history. Gene therapy, in plain terms, is a treatment that introduces corrected genetic material into a patient's cells to…

health1 MIN

38HEALTH

A rare genetic variant raises lung cancer risk 25-fold in people who have never smoked

Researchers have identified a rare genetic variant tied to a 25-fold increase in lung cancer odds among people who have never smoked, according to a study published Thursday in the journal Science. A genetic variant is a small, inherited…

health2 MIN

Tomorrow · 06:00

Start tomorrow already ahead.

Five stories, a two-minute read, zero noise — the world before your first coffee.

Get the 6AM brief Back to the desk